Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.09
-0.09 (-1.10%)
At close: Jun 11, 2026, 4:00 PM EDT
8.10
+0.01 (0.12%)
After-hours: Jun 11, 2026, 4:04 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $564.61 million as of June 11, 2026. Its market cap has increased by 928.08% in one year.
Market Cap
564.61M
Enterprise Value
475.76M
1-Year Change
928.08%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $564.61M, an increase of 758.80%. That is a compound annual growth rate of 61.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 570.89M | 107.15% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 574.20M |
| Achieve Life Sciences | 562.57M |
| Rigel Pharmaceuticals | 556.54M |
| Gyre Therapeutics | 552.80M |
| MiMedx Group | 551.10M |
| First Tracks Biotherapeutics | 549.56M |
| Tectonic Therapeutic | 549.09M |
| Prime Medicine | 534.63M |